Breaks Categories: News

WednesdayJun 29, 2022 11:34 am

NetworkNewsBreaks – SPYR Inc. (SPYR) Shares GeoTraq Update

SPYR (OTCQB: SPYR), dba SPYR Technologies, a diversified technology company developing products and leveraging the Internet of Things (“Iot”) for large-scale applications and industries, has released an update regarding GeoTraq, its recent acquisition. The update comes from GeoTraq chief technology officer Pierre Parent, who noted that the GeoTraq team is “elated” to be part of SPYR and what that means in its ability to develop technology and use the IoT in truly massive, industry-altering ways. GeoTraq develops and manufactures self-contained and ultra-small Mobile IoT modules for asset tracking, location-based services, and sensor modules for remote monitoring. According to the announcement, the modules…

Continue Reading

TuesdayJun 28, 2022 1:30 pm

NetworkNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Can Enable ‘New Breed of Farmers’

Advanced Container Technologies (OTC: ACTX) today announced that GrowPods — transportable modular hydroponic farms — can help democratize food production around the world. Technology has made farming easier since the arrival of the plow thousands of years ago. Farmers now have access to advanced robots, automated facilities, self-driving tractors, and pollinator drones. With technology, community groups, entrepreneurs, schools, and all types of organizations are enabled to grow their own fruits and vegetables, as automated systems like GrowPods have made it simple for anyone to become a farmer. “GrowPods can be placed virtually anywhere and can grow the equivalent of three…

Continue Reading

TuesdayJun 28, 2022 1:10 pm

NetworkNewsBreaks – GreenBox POS (NASDAQ: GBOX) Issues Letter to Shareholders

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing financial technology company, today announced a CEO letter to shareholders. In the letter, GBOX Chief Executive Officer Fredi Nisan discussed the company’s maturation over the years and his encouragement in the company’s accomplishments and future. “No doubt, we are keenly aware of volatile changes in the competitive landscape and business environment that have left numerous organizations rethinking their strategy. Nonetheless, we remain laser-focused on the long-term execution of our business strategy, with steadfast confidence in our highly differentiated technology,” Nisan stated. “Our commitment to driving shareholder value is not, and should not,…

Continue Reading

TuesdayJun 28, 2022 12:47 pm

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Adelia Announce Achievement of Milestone

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, a biotechnology company focused on progressing Psychedelics to Therapeutics(TM), and its wholly controlled subsidiary Adelia Therapeutics Inc., have announced the achievement of a key milestone. The milestone is identified as Y2, Q3 in the contribution agreement created between Adelia and Cybin when the company acquired Adelia. Reaching the milestone means that an estimated 37,366.2 class B common shares in Cybin will be issued to Adelia shareholders; the issuance of the shares represents the approximately $217,465 that Cybin agreed to pay if the key milestone was achieved. Adelia…

Continue Reading

MondayJun 27, 2022 2:28 pm

NetworkNewsBreaks – Industrial Nanotech Inc. (INTK) Releases Revised Revenue Guidance

Industrial Nanotech (OTC: INTK), a global nanoscience solutions and research leader, is reporting revised revenue guidance. According to the announcement, INTK has implemented adjustments in revenue strategy designed to support the company’s success and growth during what executives anticipate may be an economically challenging two or three years. “Our quarterly revenue numbers continue to grow exponentially and remain greater than any other period in the Company’s history,” said Industrial Nanotech CEO Stuart Burchill in the press release. “However, our previously stated objective of doubling our revenue numbers every quarter in 2022, starting with our Q1 2022 quarterly revenue record of…

Continue Reading

MondayJun 27, 2022 2:23 pm

NetworkNewsBreaks – IBN to Provide Compelling Real-Time Coverage of Driving Mobility 9

IBN (“InvestorBrandNetwork”), an innovative corporate communications firm and content distributor, today announced its collaboration with Sustain Southern California (“Sustain SoCal”) to heighten the visibility of Driving Mobility - the 9th Annual Transportation Conference (“Driving Mobility 9”). The event is slated to take place from 1-5 pm on June 29, 2022, at UCI Beall Applied Innovation in Irvine, California, with an EXPO and reception to follow. “Our team at IBN is excited to work alongside Sustain SoCal once again for the upcoming Driving Mobility 9 event,” said Jonathan Keim, communications director for IBN. “They are incredibly professional, and we look forward…

Continue Reading

MondayJun 27, 2022 2:19 pm

NetworkNewsBreaks – SPYR Technologies (SPYR) Announces Strategic Engagement of Integrity Media

SPYR (OTCQB: SPYR), a diversified technology company developing products leveraging the internet of things (“Iot”) for large scale applications and industries, is pleased to announce that it has retained veteran agency Integrity Media to manage its investor relations and corporate communication efforts. “Integrity Media is a well-established and respected investor relations firm with a reputation for consistent and clearly written communication and for their efforts in advocating for investors,” said Tim Matula, CEO and president of SPYR Technologies. “In our conversations with Mr. Divich about representing SPYR, he was adamant as to a public company’s obligation to be transparent with…

Continue Reading

MondayJun 27, 2022 2:11 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Releases Report of Annual General Meeting of Shareholders

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a life-sciences holding company dedicated to building a portfolio of assets and biotech solutions, is reporting on its annual general meeting of shareholders; the meeting was held online on June 23, 2022. During the meeting, seven nominees were elected as directors of the company. The new directors are Anthony Durkacz, Zeeshan Saeed, Donal Carroll, Adnan Bashir, Fernando Cugliari, Nitin Kaushal and Lawrence Latowsky; the directors will serve until the next annual meeting of shareholders or until successors are elected or appointed. During the meeting, shareholders also reappointed MNP LLP as the company…

Continue Reading

MondayJun 27, 2022 2:05 pm

NetworkNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Expands Collaboration Efforts with Tier 1 Supplier of Automotive Lighting Equipment

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, and Koito Manufacturing Co. Ltd (TSE: 7276), a leading automotive lighting equipment tier-1 supplier, jointly announced their intention to expand existing collaboration efforts to include select future Cepton lidar products and go-to-market activities. According to the update, detailed commercial terms are under discussion. “In the past five years, our team has successfully collaborated with Koito to commercialize and scale the manufacturing of Cepton’s lidar technology,” said Jun Pei, Cepton’s co-founder and CEO. “Expanded collaboration will further strengthen the Koito-Cepton partnership and better positions both companies to…

Continue Reading

MondayJun 27, 2022 1:53 pm

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Moving Forward with Phase 1/2a Clinical Trial after Receiving Key FDA Approval

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has received approval from the U.S. Food and Drug Administration (“FDA”) to proceed with its phase 1/2a first-in-human clinical trial evaluating CYB003; the company has received a “may proceed” letter and investigational new drug application (“IND”) clearance from the FDA. The approval means that CYB003 will be the first  novel psilocybin analog to enter clinical development, with patient recruitment beginning immediately and pharmacokinetic and safety data readout anticipated by fourth quarter 2022. According to the announcement, Cybin’s CYB003 is a proprietary deuterated psilocybin analog being developed for…

Continue Reading